Increased viscosity of hemoglobin-based oxygen carriers retards NO-binding when perfused through narrow gas-permeable tubes

Microvasc Res. 2011 Mar;81(2):169-76. doi: 10.1016/j.mvr.2010.12.002. Epub 2010 Dec 16.

Abstract

Increased fluid viscosity of a solution of hemoglobin-based oxygen carriers (HBOCs) reduces vasoconstrictive effects because increased shear stress on the vascular wall enhances the production of vasorelaxation factors such as NO. Nevertheless, on a microcirculatory level, it remains unclear how viscosity affects the reaction of HBOCs and NO. In this study, different HBOCs were perfused through narrow gas-permeable tubes (25 μm inner diameter at 1 mm/s centerline velocity; hemoglobin concentration [Hb]=5 g/dL). The reaction was examined microscopically based on the Hb visible-light absorption spectrum. When immersed in a NO atmosphere, the NO-binding of deoxygenated Hb solution (viscosity, 1.1 cP at 1000 s(-1)) in the tube occurred about twice as rapidly as that of red blood cells (RBCs): 1.6 cP. Binding was reduced by PEGylation (PEG-Hb, 7.7 cP), by addition of a high molecular weight hydroxyethyl starch (HES) (2.8 cP), and by encapsulation to form Hb-vesicles (HbVs, 1.5 cP; particle size 279 nm). However, the reduction was not as great as that shown for RBCs. A mixture of HbVs and HES (6.2 cP) showed almost identical NO-binding to that of RBCs. Higher viscosity and particle size might reduce lateral diffusion when particles are flowing. The HbVs with HES showed the slowest NO-binding. Furthermore, Hb encapsulation and PEGylation, but not HES-addition, tended to retard CO-binding. Increased viscosity reportedly enhances production of endothelium NO. In addition, our results show that the increased viscosity also inhibits the reaction with NO. Each effect might mitigate vasoconstriction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Substitutes / chemistry
  • Blood Substitutes / metabolism*
  • Carbon Monoxide / metabolism
  • Erythrocytes / cytology
  • Erythrocytes / metabolism
  • Hemoglobins / administration & dosage
  • Hemoglobins / chemistry
  • Hemoglobins / metabolism*
  • Humans
  • Hydroxyethyl Starch Derivatives / chemistry
  • Liposomes
  • Microfluidics*
  • Nitric Oxide / metabolism*
  • Particle Size
  • Perfusion*
  • Polyethylene Glycols / chemistry
  • Polyethylene Glycols / metabolism
  • Protein Binding
  • Spectrophotometry
  • Viscosity

Substances

  • Blood Substitutes
  • Hemoglobins
  • Hydroxyethyl Starch Derivatives
  • Liposomes
  • PEG-hemoglobin
  • Nitric Oxide
  • Polyethylene Glycols
  • Carbon Monoxide
  • deoxyhemoglobin